Oligodendrocytes: biology and pathology
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
Oligodendrocytes are the myelinating cells of the central nervous system (CNS). They are the end product of a cell lineage which has to undergo a complex and precisely timed program of proliferation, migration, differentiation, and myelination to finally produce the insulating sheath of axons. Due to this complex differentiation program, and due to their unique metabolism/physiology, oligodendrocytes count among the most vulnerable cells of the CNS. In this review, we first describe the different steps eventually culminating in the formation of mature oligodendrocytes and myelin sheaths, as they were revealed by studies in rodents. We will then show differences and similarities of human oligodendrocyte development. Finally, we will lay out the different pathways leading to oligodendrocyte and myelin loss in human CNS diseases, and we will reveal the different principles leading to the restoration of myelin sheaths or to a failure to do so.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Fig. 2 Myelin and oligodendrocyte pathology in autoimmune encephalomyelitis, multiple sclerosis, and stroke. a–d Chronic autoimmune encephalomyelitis, induced in DA rat by active sensitization with MOG fusion protein; a massive demyelination is seen in the cerebellar white matter, ×6; b–d oligodendrocytes in different lesion stages of EAE; in the peri-plaque white matter myelin (red) is present and multiple oligodendrocytes with PLP mRNA (black) are seen (b); in the active lesions myelin falls apart, myelin fragments are taken up by macrophages (red granules) and oligodendrocytes are lost (c); in more advanced lesions no macrophages with early myelin degradation products are present; numerous oligodendrocytes re-appear in the lesions, apparently recruited from progenitor cells (black cells), followed by rapid and extensive remyelination; immunocytochemistry for PLP and in situ hybridization for PLP mRNA, ×1000; e–h chronic multiple sclerosis case with extensive remyelination within the CNS; This hemispheric brain section contains 3 active lesions, 4 demyelinated plaques, and 8 remyelinated shadow plaques, ×1.2; f–h double staining for PLP protein (red) and PLP mRNA (black) in one of the active lesions shows a similar pattern as described before in EAE; many oligodendrocytes in the peri-plaque white matter (f); oligodendrocyte loss in the zone of active demyelination (g) and reappearance of oligodendrocytes in the inactive zone, closely adjacent to the zone of activity (h), ×500; i–o myelin changes in the initial stage of a lesion in white matter stroke; LFB shows pale myelin staining (i); the axons, stained with Bielschowsky silver impregnation are largely preserved (k); MAG (l) and CNPase (m) are completely lost from the lesions, while the myelin proteins within the compact sheath (PLP; n) or on the oligodendrocyte surface (MOG; o) are preserved, ×20; p–s acute multiple sclerosis with lesions following a pattern of hypoxia-like tissue injury (Pattern III, [109]). p The section contains areas of initial demyelination (i), early active demyelination (a) and late active or inactive portions (d); q serial section of p, stained by immunocytochemistry for PLP; Only the late active and inactive lesions show loss of PLP; in the active portions (a) a minor loss of PLP reactivity is seen, while in the initial lesions PLP reactivity is the same as in the normal appearing white matter, ×3; r and s edge of an active lesion showing partial preservation of immunoreactivity for MOG (r), but extensive and complete loss of MAG(s), ×20](https://figures.cochat.ai/paper-figures/777f35f33b804c4caf0983c7191aaa36/oligodendrocytes-biology-and-pathology-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, module 14 was enriched in genes involved in myelination49 and blood-brain barrier,50 consistent with the high enrichment of oligodendrocyte populations in the fiber tracts, and indicated blood-brain barrier changes in the thalamus.”
From SCING: Inference of robust, interpretable gene regulatory networks from single cell and spatial transcriptomics (2023) · cites this paper as [49]
The cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes have a high metabolic rate and must produce large amounts of membranes and protein, particularly during myelination (Bradl & Lassmann, 2010).”
From Brain structure, working memory and response inhibition in childhood leukemia survivors (2017) · cites this paper as Bradl & Lassmann, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050304 · Cited by 2,288
Regional Development of the Brain in Early Life
(1968) · Archives of Disease in Childhood · doi:10.1136/adc.43.229.388 · Cited by 2,090
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Ruiter, A. M., Meilof, J. F., Somanje-Bolweg, R. R. J., van Gorsel, E., & Kalkers, N. F. (2017) · Case Reports in Neurology · doi:10.1159/000455942 · Cited by 1,762
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Interneuron Migration from Basal Forebrain to Neocortex: Dependence on Dlx Genes
Anderson, S. A., Eisenstat, D. D., Shi, L., & Rubenstein, J. L. R. (1997) · Science · doi:10.1126/science.278.5337.474 · Cited by 1,462
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citation
Research works printed but not linked: 1
- Schlesinger H Zur Frage der akuten Multiplen Sklerose und der encephalomyelitis disseminata im Kindesalter Arb Neurol Inst (Wien) 1909 17 410 432
Cited by
Items 301–400 of 943
Shaw, J. C., Crombie, G. K., Palliser, H. K., & Hirst, J. J. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.618052 · Cited by 30
Liu, M., Yu, W., Zhang, F., Liu, T., Li, K., Lin, M., Wang, Y., Zhao, G., & Jiang, J. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s296398 · Cited by 29
“inflammation, induce nerve fiber degeneration and myelin loss.(46,47) This study used LFB staining to evaluate the structural integrity of myelin in the spinal cord after three treatment weeks.”
MethodIron Transporters and Ferroptosis in Malignant Brain Tumors
Zhao, J., Wang, Y., Tao, L., & Chen, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.861834 · Cited by 34
Alterations of juxtaparanodal domains in two rodent models of CNS demyelination
Zoupi, L., Markoullis, K., Kleopa, K. A., & Karagogeos, D. (2013) · Glia · doi:10.1002/glia.22511 · Cited by 33
“…alterations or damage as preceding macrophage and microglia recruitment in newly formed MS lesions has been put forward (Barnett et al., 2006; Bradl and Lass- mann, 2010; Franklin et al., 2012; Haider et al., 2011; Lassmann, 2001, 2003; Lassmann et al., 2001; Lassmann and Lucchinetti, 2008).”
BackgroundSimone, J. J., Green, M. R., Hodges, T. E., & McCormick, C. M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.012 · Cited by 32
Zhu, Y., Zhang, Y., He, S., Yi, S., Feng, H., Xia, X., Fang, X., Gong, X., & Zhao, P. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03161-0 · Cited by 36
“Specifically, neurons were characterized by the expression of Syt1 [38], oligodendrocytes exhibited the marker Cldn1 [39], and oligodendrocyte precursor cells displayed Pdgfra expression [40–42].”
BackgroundRodrígues-Amorím, D., Bozzelli, P. L., Kim, T., Liu, L., Gibson, O., Yang, C.-Y., Murdock, M. H., Galiana-Melendez, F., Schatz, B., Davison, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51003-7 · Cited by 34
Komatsu, H., Takeuchi, H., Kikuchi, Y., Ono, C., Yu, Z., Iizuka, K., Takano, Y., Kakuto, Y., Funakoshi, S., Ono, T., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa049 · Cited by 28
Effect of retinoic acid on the neurovascular unit: A review
Pouso, M. R., & Cairrão, E. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.011 · Cited by 29
Glia: guardians, gluttons, or guides for the maintenance of neuronal connectivity?
Jebelli, J. D., Su, W., Hopkins, S., Pocock, J. M., & Garden, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12711 · Cited by 29
Revuelta, M., Arteaga, O., Alvarez, A., Martínez-Ibargüen, A., & Hilario, E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9724-6 · Cited by 26
The progeroid gene BubR1 regulates axon myelination and motor function
Choi, C.-I., Yoo, K. H., Hussaini, S. M. Q., Jeon, B. T., Welby, J., Gan, H., Scarisbrick, I. A., Zhang, Z., Baker, D. J., van Deursen, J. M., et al. (2016) · Aging · doi:10.18632/aging.101032 · Cited by 26
Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
Gacem, N., & Nait‐Oumesmar, B. (2021) · Life · doi:10.3390/life11040327 · Cited by 34
“They are generated after an orchestrated process of specification (switch of neural progenitors’ cells from producing neuronal to glial cells), proliferation, migration and differentiation during brain, optic nerve and spinal cord development [2].”
BackgroundBauch, J., & Faissner, A. (2022) · Cells · doi:10.3390/cells11111773 · Cited by 29
“In a healthy organism, spontaneous remyelination processes occur in the demyelinated CNS, however, these do not suffice for a complete regeneration [13].”
BackgroundInfluentialDermitzakis, I., Μanthou, M. E., Meditskou, S., Miliaras, D., Kesidou, E., Boziki, M. K., Petratos, S., Grigoriadis, N., & Theotokis, P. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44070222 · Cited by 26
“These cells become post-mitotic, exiting the cell cycle to express a substantial amount of myelin-associated proteins and differentiate into mature pre-myelinating OLs [23].”
BackgroundMaurya, S. K., Gupta, S., & Mishra, R. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1072046 · Cited by 29
“Clearance of debris and proliferation of oligodendrocytes are essential remyelination processes, followed by recruitment and proliferation of OPCs, which differentiate into mature myelinating oligodendrocytes (Bradl and Lassmann, 2010).”
BackgroundNeuroglia as targets for drug delivery systems: A review
Madhusudanan, P., Reade, S., & Shankarappa, S. A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.08.013 · Cited by 27
The Influence of Murine Genetic Background in Adeno-Associated Virus Transduction of the Mouse Brain
He, T., Itano, M. S., Earley, L. F., Hall, N. E., Riddick, N., Samulski, R. J., & Li, C. (2019) · Human Gene Therapy Clinical Development · doi:10.1089/humc.2019.030 · Cited by 25
“For packaging of rAAV vectors, the classical three-plasmidbased production method was used.(21) Briefly, 293 cells were cotransfected with three plasmids consisting of an AAV helper plasmid (AAV2 Rep and the AAV Cap from serotypes AAV2, 5, 7, 8, or 9), a vector plasmid containing the ITRs from AAV2 flanking an EGFP tr…”
BackgroundMethodInfluentialGlial Cell Dynamics in Neuroinflammation: Mechanisms, Interactions, and Therapeutic Implications
García‐Domínguez, M. (2026) · Biomedicines · doi:10.3390/biomedicines14010115 · Cited by 36
“To facilitate rapid saltatory conduction of action potentials and ensure effective neural communication over long distances, oligodendrocytes are responsible in the formation and maintenance of myelin sheaths around axons in the CNS [61].”
Salehpour, M. Y., Mollica, A., Momtaz, S., Sanadgol, N., & Farzaei, M. H. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00793-6 · Cited by 25
The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
Raftopoulou, S., Rapti, A., Karathanasis, D., Evangelopoulos, M., & Mavragani, C. P. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1026449 · Cited by 26
Sengottuvel, V., Hota, M., Oh, J., Galam, D. L. A., Wong, B. H., Wenk, M. R., Ghosh, S., Torta, F. T., & Silver, D. L. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164118 · Cited by 25
“Disruption along any of these steps can lead to deleterious consequences ranging from oligodendrocyte death to hypomyelination to precocious hypermyelination (40).”
Up-regulation of VCAM1 Relates to Neuronal Apoptosis After Intracerebral Hemorrhage in Adult Rats
Zhang, D., Yuan, D., Shen, J., Yan, Y., Chen, G., Gu, J., Xue, H., Qian, Y., Zhang, W., He, X., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1561-x · Cited by 30
The p35/CDK5 signaling is regulated by p75NTR in neuronal apoptosis after intracerebral hemorrhage
Zhou, T., Wang, H., Shen, J., Li, W., Cao, M., Hong, Y., & Cao, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28244 · Cited by 27
Bergs, J. W. J., Morr, A. S., Silva, R. V., Infante‐Duarte, C., & Sack, I. (2024) · Advanced Science · doi:10.1002/advs.202402338 · Cited by 36
Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
Nguyen, A. T., Kouri, N., Labuzan, S. A., Przybelski, S. A., Lesnick, T. G., Raghavan, S., Reid, R. I., Reichard, R. R., Knopman, D. S., Petersen, R. C., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02465-w · Cited by 26
Oligodendrocyte lineage cells: Advances in development, disease, and heterogeneity
Wang, J., Gao, M.-Y., Gao, R., Zhao, K., Zhang, Y., & Li, X. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15728 · Cited by 24
“OLs are myelin- forming cells of the CNS, while myelin is a highly specialized class of protein and lipid- rich membrane that surrounds neuronal axons and is necessary for hopping saltatory conduction along the axons (Bradl & Lassmann, 2010; Nave & Werner, 2014).”
BackgroundPotentially toxic elements in the brains of people with multiple sclerosis
Pamphlett, R., Buckland, M. E., & Bishop, D. (2023) · Scientific Reports · doi:10.1038/s41598-022-27169-9 · Cited by 27
Sun, H., Li, L., Zhou, F., Zhu, L., Ke, K., Tan, X., Xu, W., Rui, Y., Zheng, H., Zhou, Z., et al. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9489-4 · Cited by 24
Biallelic mutations in the homeodomain of NKX6-2 underlie a severe hypomyelinating leukodystrophy
Dorboz, I., Aiello, C., Simons, C., Stone, R. T., Niceta, M., Elmaleh, M., Abuawad, M., Doummar, D., Bruselles, A., Wolf, N. I., et al. (2017) · Brain · doi:10.1093/brain/awx207 · Cited by 24
Song, C. H., Clark, S. M., Vaughn, C. N., Nicholson, J. D., Murphy, K. J., Mou, T.-C. M., Schwarcz, R. M., Hoffman, G. E., & Tonelli, L. H. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.001 · Cited by 28
Jamieson, D., Broadhouse, K. M., McLoughlin, L. T., Schwenn, P., Parker, M. J., Lagopoulos, J., & Hermens, D. F. (2020) · Journal of Adolescence · doi:10.1016/j.adolescence.2020.06.008 · Cited by 23
Effects of a Diabetic Microenvironment on Neurodegeneration: Special Focus on Neurological Cells
Chavda, V. K., Yadav, D., Patel, S. S., & Song, M. (2024) · Brain Sciences · doi:10.3390/brainsci14030284 · Cited by 29
“Both glial cell types arise distinctly; Schwann cells originate from neural crest derivatives, whereas cerebral and spinal cord oligodendrocytes arise from the subventricular zone and ventral neural tube precursors, respectively [87,88].”
BackgroundOligodendrocyte-specific ATF4 inactivation does not influence the development of EAE
Yue, Y., Stanojlović, M., Lin, Y., Karsenty, G., & Lin, W. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1415-6 · Cited by 24
Hu, X., Xiao, G., He, L., Niu, X., Li, H., Lou, T., Hu, Q., Yang, Y., Xu, Q., Wei, Z., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2922-20.2021 · Cited by 22
“Oligodendrocyte injury can be induced by genetic factors, autoimmune responses, or microenvironmental insults from ischemia, trauma, viruses, or toxins, leading to demyelinating diseases (8).”
BackgroundInfluentialCleland, N. R. W., & Bruce, K. D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.012 · Cited by 25
The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance
Doghish, A. S., Elazazy, O. E., Mohamed, H. H., Mansour, R. M., Ghanem, A., Faraag, A. H. I., Elballal, M. S., Elrebehy, M. A., Elesawy, A. E., Mageed, S. S. A., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154880 · Cited by 24
Mechanisms Governing Oligodendrocyte Viability in Multiple Sclerosis and Its Animal Models
Lei, Z., & Lin, W. (2024) · Cells · doi:10.3390/cells13020116 · Cited by 25
“In MS and EAE, oligo-dendrocytes face destruction from both specific, cell-selective immune mechanisms and non-specific bystander mechanisms [11–13].”
BackgroundHohnholt, M. C., & Dringen, R. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0585-7 · Cited by 26
Increased population of oligodendroglia-like cells in pediatric intractable epilepsy
Sakuma, S., HALLIDAY, W. C., Nomura, R., Ochi, A., & Otsubo, H. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.002 · Cited by 23
Jenkins, S. I., Pickard, M. R., Khong, M., Smith, H., Mann, C. L. A., Emes, R. D., & Chari, D. M. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400167n · Cited by 25
Oligodendrocyte Physiology and Pathology Function
Kipp, M. (2020) · Cells · doi:10.3390/cells9092078 · Cited by 26
When glia meet induced pluripotent stem cells (iPSCs)
Li, L., & Shi, Y. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103565 · Cited by 27
Fessel, J. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12242 · Cited by 26
Transcription Blockage by DNA Damage in Nucleotide Excision Repair-Related Neurological Dysfunctions
Kajitani, G. S., Nascimento, L. L. D. S., Neves, M. R. D. C., Leandro, G. D. S., Garcia, C. C. M., & Menck, C. F. M. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.10.009 · Cited by 22
Glial Cells Response in Stroke
Jadhav, P., Karande, M., Sarkar, A., Sahu, S., Sarmah, D., Datta, A., Chaudhary, A., Kalia, K., Sharma, A., Wang, X., et al. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01183-3 · Cited by 26
Bub, A., Brenna, S., Alawi, M., Kügler, P., Gui, Y., Kretz, O., Altmeppen, H. C., Magnus, T. U., & Puig, B. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04357-4 · Cited by 23
“A Western blots of sBDEVs samples from tMCAO and shams (n = 5 per group) blotted for cell-type-specific markers: PLP and CNP1 are used as protein markers for oligodendrocytes (orange frame); synapsin 1 (Syn1) and NCAM as markers for neurons (green); EAAT1 and EAAT2 as protein markers for astrocytes (pink) and P2Y12 an…”
BackgroundInfluentialLamin B1 as a key modulator of the developing and aging brain
Koufi, F., Neri, I., Ramazzotti, G., Rusciano, I., Mongiorgi, S., Marvi, M. V., Fazio, A., Shin, M., Kosodo, Y., Cani, I., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1263310 · Cited by 28
“Even though oligodendrocytes in humans are more and larger than in rodents, their density per white matter volume in humans and rodents is very similar (Bradl and Lassmann, 2010; Budday et al., 2015).”
BackgroundLópez‐Barneo, J., de Tassigny, X. D., Sirerol-Piquer, M. S., Gómez‐Pinedo, U., Pardal, R., Bonilla, S., Capilla‐González, V., de la Torre, J., García‐Verdugo, J. M., & López‐López, I. (2015) · Hypoxia · doi:10.2147/hp.s78248 · Cited by 25
“These observations fit with previous studies describing the high-energy demands of oligodendrocytes and their particular sensitivity to ischemic damage (for review and references, see Bradl and Lassmann 48 ).”
Wang, T., Jia, L., Lv, B., Liu, B., Wang, W., Wang, F., Yang, G., Bu, X., Yao, L., & Zhang, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.003 · Cited by 24
She, P., Bunpo, P., Cundiff, J. K., Wek, R. C., Harris, R. A., & Anthony, T. G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.498469 · Cited by 24
Gupta, R. K., Saha, P., Sen, T., & Sen, N. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.015 · Cited by 25
“The oligodendrocyte progenitor cells (OPCs) persist in substantial numbers in the adult optic nerve in a quiescent state and provide a source of new oligodendrocytes after injury [14,15].”
BackgroundMethodInfluentialKatano, M., Kajimoto, K., Iinuma, M., Azuma, K., & Kubo, K. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.40241 · Cited by 24
“Like mitochondria, myelin sheath is selectively vulnerable to oxidative stress [41].”
BackgroundKV7/KCNQ Channels Are Functionally Expressed in Oligodendrocyte Progenitor Cells
Wang, W., Gao, X.-F., Xiao, L., Xiang, Z., & He, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021792 · Cited by 24
“Oligodendrocytes are generated from oligodendroglial progenitor cells (OPCs) which proliferate in the subventricular zone and migrate to formative white matter regions, where they further proliferate, differentiate, and form myelin sheaths around axons [24,25].”
BackgroundZarrouk, A., Salem, Y. B., Hafsa, J., Sghaier, R., Charfeddine, B., Limem, K., Hammami, M., & Majdoub, H. (2018) · Biochimie · doi:10.1016/j.biochi.2018.06.027 · Cited by 23
Lee, J. B., Affeldt, B. M., Gamboa, Y., Hamer, M., Dunn, J. F., Pardo, A. C., & Obenaus, A. (2018) · Developmental Neuroscience · doi:10.1159/000494134 · Cited by 23
Molecular biology of autism’s etiology – An alternative mechanism
Steinman, G., & Mankuta, D. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109272 · Cited by 24
“Myelination of new neurons in the CNS of the human fetus begins in 24–25weeks post-conception [24].”
BackgroundDamiano, S., Rosa, G. L., Sozio, C., Cavaliere, G., Trinchese, G., Raia, M., Paternò, R., Mollica, M. P., Avvedimento, V. E., & Santillo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052621 · Cited by 23
Jansen, M. I., Broome, S. T., & Castorina, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094788 · Cited by 21
“In healthy conditions, CNS myelin is produced by mature/fully differentiated OLs, whereas OL precursor cells (OPCs) are a proliferative group of progenitor cells that can differentiate into mature OLs, allowing both adaptive myelination and the regeneration of myelin following injury or disease [32,33].”
BackgroundThe multifaceted role of LRRK2 in Parkinson's disease: From human iPSC to organoids
Oun, A., Sabogal-Guáqueta, A. M., Galuh, S., Alexander, A., Kortholt, A., & Dolga, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105837 · Cited by 24
Suryana, E., & Jones, N. M. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.06.007 · Cited by 22
“All stages of the myelination process are potentially vulnera- ble to insults that may occur throughout brain development (Bradl and Lassmann, 2010; Jakovcevski et al., 2009).”
BackgroundCamacho‐Morales, A., Huang, J. K., Delint‐Ramírez, I., Tan, C. Y., Fuller, M., Lelliott, C. J., Vidal‐Puig, A., & Franklin, R. J. M. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12281 · Cited by 24
“…delta and beta nuclear receptors have been proposed as an important regulator of oligodendrocyte lineage (Saluja et al., 2001; Roth et al., 2003; Leisewitz et al., 2008; Bradl & Lassmann, 2010), and recently, it has been suggested that PGC1a is involved in post-natal myelination in the striatum.”
BackgroundAutoimmune Versus Oligodendrogliopathy: The Pathogenesis of Multiple Sclerosis
Nakahara, J., Aiso, S., & Suzuki, N. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0094-x · Cited by 27
Mole, J. P., Fasano, F., Evans, J., Sims, R., Hamilton, D. A., Kidd, E., & Metzler-Baddeley, C. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.014 · Cited by 20
Laminins and the blood-brain barrier
Nasrollahi, A., & Yao, Y. (2025) · Matrix Biology · doi:10.1016/j.matbio.2025.02.005 · Cited by 19
Rayatpour, A., Farhangi, S., Verdaguer, E., Olloquequi, J., Ureña, J. M., Auladell, C., & Javan, M. (2021) · Pharmaceuticals · doi:10.3390/ph14101031 · Cited by 21
Mercury neurotoxicity in gold miners
Lopez, M. E. C., Augusto‐Oliveira, M., Lopes-Araújo, A., Santos-Sacramento, L., Monteiro, J. R. S., da Rocha, F. F., & Arrifano, G. D. P. (2022) · Advances in neurotoxicology · doi:10.1016/bs.ant.2022.04.003 · Cited by 23
The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
Busch, L., Eggert, S., Endres, K., & Bufe, B. (2022) · Cells · doi:10.3390/cells11213421 · Cited by 23
“Oligodendrocytes are myelinating glial cells of the central nervous system that produce the insulating sheath of axons, which is essential for enhancing axonal action potential conduction [54,55].”
BackgroundIL-10/β-Endorphin-Mediated Neuroimmune Modulation on Microglia during Antinociception
Belo, T. C. A., Santos, G. X., da Silva, B. E. G., Rocha, B. L. G., Abdala, D. W., Freire, L. A. M., Rocha, F. S., & Galdino, G. (2023) · Brain Sciences · doi:10.3390/brainsci13050789 · Cited by 25
“Oligodendrocytes are essential for axonal myelination in the central nervous system (CNS), playing a critical role in maintaining the integrity and function of neuronal circuits [14].”
Oligodendrocytes in central nervous system diseases: the effect of cytokine regulation
Zhang, C., Qiu, M. S., & Fu, H. Q. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.392854 · Cited by 23
“Without communications with neurons, the proliferation and differentiation of OPCs will be disturbed, which is detrimental to remyelination after injury (Bradl and Lassmann, 2010).”
BackgroundTauheed, A. M., Ayo, J. O., & Kawu, M. U. (2016) · Pathophysiology · doi:10.1016/j.pathophys.2016.05.007 · Cited by 26
Chao, H., Liu, Y., Lin, C., Xu, X., Li, Z., Bao, Z., Fan, L., Tao, C., Zhao, L., Liu, Y., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.006 · Cited by 22
Scalisi, J., Balau, B., Deneyer, L., Bouchat, J., Gilloteaux, J., & Nicaise, C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135665 · Cited by 18
“Indeed, it has been well described that oligodendrocytes are vulnerable towards various non-physiological insults, such as oxidative stress, glutamate excitotoxicity, ATP release toxicity, inflammatory mediators, antibodies or complement-mediated attack, or other blood components (review in [16]).”
BackgroundA timeline of oligodendrocyte death and proliferation following experimental subarachnoid hemorrhage
Peng, K., Koduri, S., Ye, F., Yang, J., Keep, R. F., Xi, G., & Hua, Y. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13812 · Cited by 19
Ning, X., Tao, T., Shen, J., Ji, Y., Xie, L., Wang, H., Liu, N., Xu, X., Sun, C. C., Zhang, D., et al. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0391-y · Cited by 21
Kupferman, A., & Leibowitz, H. M. (1975) · PubMed · Cited by 26
Gaertner, Z. A., Oram, C., Schneeweis, A. K., Schonfeld, E., Bolduc, C., Chen, C., Dombeck, D. A., Parisiadou, L., Poulin, J.-F., & Awatramani, R. B. (2025) · eLife · doi:10.7554/elife.101035 · Cited by 31
Sheikhi, K., Ghaderi, S., Firouzi, H., Rahimibarghani, S., Shabani, E., Afkhami, H., & Yarahmadi, A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1517369 · Cited by 20
Ke, K., Li, L., Rui, Y., Zheng, H., Tan, X., Xu, W., Cao, J., Xu, J., Cui, G., Xu, G., et al. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9970-2 · Cited by 19
“Pathologic changes of ICH include neuronal apoptosis, astrocyte proliferation, and oligodendrocyte death (Bradl and Lassmann 2010; Gong et al. 2001; Sukumari-Ramesh et al. 2012).”
BackgroundFocal cerebral ischemia induces changes in oligodendrocytic tau isoforms in the damaged area
Villa-González, M., Vallés‐Saiz, L., Hernández, I. H., Ávila, J., Hernández, F., & Pérez-Álvarez, M. J. (2020) · Glia · doi:10.1002/glia.23865 · Cited by 18
Acquired Brain Injuries Across the Perinatal Spectrum: Pathophysiology and Emerging Therapies
Russ, J. B., & Ostrem, B. E. L. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.08.001 · Cited by 21
Yadav, V., Mythri, C., & Kumarasamy, M. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100048 · Cited by 28
Kuronen, M., Hermansson, M., Manninen, O., Zech, I., Talvitie, M., Laitinen, T., Gröhn, O. H. J., Somerharju, P. J., Eckhardt, M., Cooper, J. D., et al. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01233.x · Cited by 22
Padhi, B. K., & Pelletier, G. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.07.011 · Cited by 21
Picone, S., Ritieni, A., Fabiano, A., Graziani, G., Paolillo, P., Volti, G. L., Galvano, F., & Gazzolo, D. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.11.017 · Cited by 19
“bolic rates during peak myelination [34,35], and iv) the correlation with the aminoacid neurotransmitters GABA and aspartate, involved in the modulation of neuronal proliferation and maturation, neurite outgrowth and synapse formation and neurotransmission [36–39].”
BackgroundMemantine Mitigates Oligodendrocyte Damage after Repetitive Mild Traumatic Brain Injury
Ma, G., Liu, C., Hashim, J., Conley, G. M., Morriss, N. J., Meehan, W. P., III, Qiu, J., & Mannix, R. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.016 · Cited by 21
Pons-Espinal, M., Blasco-Agell, L., & Consiglio, A. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03700-x · Cited by 18
Effects of central nervous system electrical stimulation on non-neuronal cells
Williams, N. P., Kushwah, N. S., Dhawan, V., Zheng, X. S., & Cui, X. T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.967491 · Cited by 20
Isolation and Characterization of Neural Stem Cells from the Rat Inferior Colliculus
Völker, J., Engert, J., Völker, C., Bieniussa, L., Schendzielorz, P., Hagen, R., & Rak, K. (2019) · Stem Cells International · doi:10.1155/2019/5831240 · Cited by 26
“These are also adjacent to neuronal cells in vivo, where they form the myelin sheaths around axons and play an essential role as a donor of neurotropic substances [60].”
BackgroundThe Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases
Zhao, M., Wang, Z., Yang, M., Ding, Y. P., Zhao, M., Wu, H., Zhang, Y., & Lu, Q. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08829-y · Cited by 20
“The process of remyelination starts with OPC activation and colonization at the injured site, where they can differentiate into mature oligodendrocytes capable of building myelin [62].”
BackgroundAdams, Y., Clausen, A. S., Jensen, P. Ø., Lager, M., Wilhelmsson, P., Henningsson, A., Lindgren, P., Faurholt‐Jepsen, D., Mens, H., Kraiczy, P., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105838 · Cited by 30
“53 While not the focus of this study, the model is expandable and to date a maximum of six different cell types have been cultured in tandem, including microglia and oligodendrocytes.”
BackgroundPhotoselective sequencing: microscopically guided genomic measurements with subcellular resolution
Mangiameli, S. M., Chen, H., Earl, A., Dobkin, J. A., Lesman, D., Buenrostro, J. D., & Chen, F. (2023) · Nature Methods · doi:10.1038/s41592-023-01845-8 · Cited by 19
The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
Fodder, K., de Silva, R., Warner, T. T., & Bettencourt, C. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01607-9 · Cited by 22
Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
Eugenín, J. L., Bernhardi, L. E.-V., & Rommy von Bernhardi, M. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1249320 · Cited by 20
Lury, A. D., Bisulca, J., Lee, J. S., Altaf, M. D., Coyle, P. K., & Duong, T. Q. (2023) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2023.120816 · Cited by 19
PIKE is essential for oligodendroglia development and CNS myelination
Chan, C. B., Liu, X., Zhao, L., Liu, G., Lee, C. W., Feng, Y., & Ye, K. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318185111 · Cited by 19
“Generation of OLs is a developmentally regulated process, which involves the proliferation of oligodendrocyte progenitor cells (OPCs) at the germinal subventricular zones (SVZ), migration throughout the CNS, differentiation into mature OLs, and adhesion to the axon to form myelin (2).”
BackgroundKatari, V., Srikanth, L., Vengamma, B., Chandrasekhar, C., Prasad, B. C. M., & Sarma, P. V. G. K. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.12.050 · Cited by 18
Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
Navarro, A., Rioseras, B., del Valle, E., Martínez‐Pinilla, E., Astudillo, A., & Tolivia, J. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00254 · Cited by 20
“As mentioned above, Apo D is expressed mainly by mature OLGs as wells as OPCs in the brain which, in turn, are ultimately responsible for the restoration of new myelin sheaths in demyelinated axons in MS (Hu et al., 2001; Bradl and Lassmann, 2010; Clemente et al., 2013; de Castro et al., 2013).”
BackgroundRoca, F. G., André, F. M., Estellés, J. M., Pradas, M. M., Mir, L. M., & Martínez‐Ramos, C. (2021) · Macromolecular Bioscience · doi:10.1002/mabi.202000391 · Cited by 20
Neuroprotection and neuroregeneration: roles for the white matter
Calzà, L., Baldassarro, V. A., Stanzani, A., Giardino, L., & Lorenzini, L. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335834 · Cited by 21
“The pathological mechanisms leading to myelin damage may act directly on the oligodendrocyte cell, or solely on myelin sheaths preserving the cell body (Bradl and Lassmann, 2010), with the OPC being induced to differentiate and form new myelin in both cases.”
Background
Metadata
- Authors
- Bradl, M., & Lassmann, H.
- Affiliations
- Medical University of Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Bradl, Monika
- Venue
- Acta Neuropathologica
- Published
- 2009-10-22
- Volume
- 119
- Issue
- 1
- Pages
- 37-53
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC2799635
- OpenAlex
- W2018558728
- Cited by
- 933
- References
- 221
- Citations by year
- 2026: 66 · 2025: 67 · 2024: 85 · 2023: 69 · 2022: 74 · 2021: 84 · 2020: 61 · 2019: 72 · 2018: 50 · 2017: 46 · 2016: 44 · 2015: 39 · 2014: 41 · 2013: 51 · 2012: 28
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Austrian Science Fund (P 19854)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- oligodendrocytes, myelination, myelin sheath, oligodendrocyte lineage, oligodendrocyte differentiation, demyelination, demyelinating disease, central nervous system
- MeSH terms
- Animals, Central Nervous System, Central Nervous System Diseases, Humans, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Species Specificity, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.